Canopy Growth (NASDAQ:CGC - Get Free Report) is scheduled to post its quarterly earnings results before the market opens on Friday, August 9th. Analysts expect Canopy Growth to post earnings of ($0.31) per share for the quarter. Persons that are interested in participating in the company's earnings conference call can do so using this link.
Canopy Growth (NASDAQ:CGC - Get Free Report) last posted its earnings results on Thursday, May 30th. The company reported ($0.28) earnings per share for the quarter, topping the consensus estimate of ($0.33) by $0.05. Canopy Growth had a negative net margin of 185.77% and a negative return on equity of 62.67%. The company had revenue of $53.99 million for the quarter, compared to analyst estimates of $52.71 million. On average, analysts expect Canopy Growth to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Canopy Growth Trading Down 3.0 %
Shares of Canopy Growth stock traded down $0.20 during trading hours on Friday, hitting $6.57. The company's stock had a trading volume of 2,777,617 shares, compared to its average volume of 9,248,214. The company has a market capitalization of $532.17 million, a PE ratio of -1.02 and a beta of 0.93. Canopy Growth has a 12 month low of $2.76 and a 12 month high of $19.20. The stock has a 50 day moving average of $7.27 and a 200 day moving average of $6.69. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.58 and a quick ratio of 1.25.
Insider Buying and Selling at Canopy Growth
In related news, Director Willy Kruh sold 3,738 shares of Canopy Growth stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $9.94, for a total transaction of $37,155.72. Following the completion of the sale, the director now owns 17,295 shares of the company's stock, valued at approximately $171,912.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders have sold 7,545 shares of company stock worth $67,997 over the last 90 days. Company insiders own 0.35% of the company's stock.
Analyst Ratings Changes
CGC has been the subject of several recent research reports. Piper Sandler reduced their price objective on Canopy Growth from $3.00 to $2.00 and set an "underweight" rating for the company in a research report on Tuesday, July 9th. Atb Cap Markets upgraded shares of Canopy Growth to a "hold" rating in a report on Monday, June 17th.
Read Our Latest Report on Canopy Growth
Canopy Growth Company Profile
(
Get Free Report)
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products.
Further Reading
Before you consider Canopy Growth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.
While Canopy Growth currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
